Methodological considerations in interpreting outcomes after biologic dose escalation in inflammatory bowel disease
Internal Medicine Journal · 09.10.2026
DOI: 10.1111/imj.70658 ↗Kurz gefasst
Leserbrief in der Zeitschrift Internal Medicine Journal, online erschienen am 09.10.2026. Verfasst von Umema Mangi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Karachi Metropolitan University, Karachi, Pakistan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Karachi Metropolitan University, Karachi, Pakistan.
- Jinnah Sindh Medical University, Karachi, Pakistan.
ORCID-Profile: Umema Mangi, Muhammad Hassan
Zitieren
APA
Mangi, U., & Hassan, M. (2026). Methodological considerations in interpreting outcomes after biologic dose escalation in inflammatory bowel disease. Internal Medicine Journal. https://doi.org/10.1111/imj.70658
Vancouver
Mangi U, Hassan M. Methodological considerations in interpreting outcomes after biologic dose escalation in inflammatory bowel disease. Internal Medicine Journal. 2026. doi:10.1111/imj.70658
BibTeX
@article{Mangi2026,
author = {Mangi, Umema and Hassan, Muhammad},
title = {Methodological considerations in interpreting outcomes after biologic dose escalation in inflammatory bowel disease},
journal = {Internal Medicine Journal},
year = {2026},
doi = {10.1111/imj.70658}
}
EUVIMED